{"entity":{"type":"insider","cik":"0001527241","url":"/insider/0001527241","json_url":"/insider/0001527241.json","name":"Silva Francisco","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":30,"n_filings":14,"first":"2017-03-01","last":"2024-04-10","span_basis":"filed_date"},"name_variants":[{"name":"Silva Francisco","source":"filing","n_filings":14,"first_seen":"2017-03-01","last_seen":"2024-04-10"}],"transactions":[{"id":2959057,"accession":"0001021771-24-000091","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001021771-24-000091","line_url":"/filing/0001021771-24-000091#line-3","is_derivative":false,"issuer_cik":"0001505497","issuer_name":"BioRestorative Therapies, Inc.","issuer_ticker":"BRTX","issuer_name_source":null,"issuer_url":"/issuer/0001505497","owner_cik":"0001527241","owner_name":"Silva Francisco","owner_display_name":"Silva Francisco","owner_url":"/insider/0001527241","role":"Director, Officer (VP of Research and Development)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Research and Development","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6600.0,"shares_display":"6,600","price_per_share":1.25,"price_display":"1.25","price_state":"stated","total_value":8250.0,"total_display":"8,250.00","total_whole":"8,250","shares_owned_after":155759.0,"shares_owned_after_display":"155,759","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-09","filed_date":"2024-04-10","scope":"insider"},{"id":2959051,"accession":"0001021771-24-000091","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001021771-24-000091","line_url":"/filing/0001021771-24-000091","is_derivative":false,"issuer_cik":"0001505497","issuer_name":"BioRestorative Therapies, Inc.","issuer_ticker":"BRTX","issuer_name_source":null,"issuer_url":"/issuer/0001505497","owner_cik":"0001527241","owner_name":"Silva Francisco","owner_display_name":"Silva Francisco","owner_url":"/insider/0001527241","role":"Director, Officer (VP of Research and Development)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Research and Development","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1708.0,"shares_display":"1,708","price_per_share":1.1588524590163933,"price_display":"1.16","price_state":"stated","total_value":1979.32,"total_display":"1,979.32","total_whole":"1,979","shares_owned_after":149159.0,"shares_owned_after_display":"149,159","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-08","filed_date":"2024-04-10","scope":"insider","n_lines":2},{"id":8400848,"accession":"0001021771-23-000086","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001021771-23-000086","line_url":"/filing/0001021771-23-000086#line-1","is_derivative":false,"issuer_cik":"0001505497","issuer_name":"BioRestorative Therapies, Inc.","issuer_ticker":"BRTX","issuer_name_source":null,"issuer_url":"/issuer/0001505497","owner_cik":"0001527241","owner_name":"Silva Francisco","owner_display_name":"Silva Francisco","owner_url":"/insider/0001527241","role":"Director, Officer (VP of Research and Development), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Research and Development","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4954.0,"shares_display":"4,954","price_per_share":2.22,"price_display":"2.22","price_state":"stated","total_value":10997.88,"total_display":"10,997.88","total_whole":"10,998","shares_owned_after":164644.0,"shares_owned_after_display":"164,644","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-31","filed_date":"2023-08-31","scope":"insider"},{"id":8012479,"accession":"0001021771-23-000034","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001021771-23-000034","line_url":"/filing/0001021771-23-000034#line-1","is_derivative":false,"issuer_cik":"0001505497","issuer_name":"BioRestorative Therapies, Inc.","issuer_ticker":"BRTX","issuer_name_source":null,"issuer_url":"/issuer/0001505497","owner_cik":"0001527241","owner_name":"Silva Francisco","owner_display_name":"Silva Francisco","owner_url":"/insider/0001527241","role":"Director, Officer (VP of Research and Development), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Research and Development","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":747.0,"shares_display":"747","price_per_share":3.56,"price_display":"3.56","price_state":"stated","total_value":2659.32,"total_display":"2,659.32","total_whole":"2,659","shares_owned_after":159690.0,"shares_owned_after_display":"159,690","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-31","filed_date":"2023-04-04","scope":"insider"},{"id":6523143,"accession":"0001567619-22-020707","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-22-020707","line_url":"/filing/0001567619-22-020707#line-1","is_derivative":false,"issuer_cik":"0001505497","issuer_name":"BioRestorative Therapies, Inc.","issuer_ticker":"BRTX","issuer_name_source":null,"issuer_url":"/issuer/0001505497","owner_cik":"0001527241","owner_name":"Silva Francisco","owner_display_name":"Silva Francisco","owner_url":"/insider/0001527241","role":"Director, Officer (VP of Research and Development)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Research and Development","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":943.0,"shares_display":"943","price_per_share":2.6162,"price_display":"2.62","price_state":"stated","total_value":2467.0766,"total_display":"2,467.08","total_whole":"2,467","shares_owned_after":166046.0,"shares_owned_after_display":"166,046","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-21","filed_date":"2022-11-21","scope":"insider"},{"id":6188716,"accession":"0001567619-22-018437","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-22-018437","line_url":"/filing/0001567619-22-018437#line-1","is_derivative":false,"issuer_cik":"0001505497","issuer_name":"BioRestorative Therapies, Inc.","issuer_ticker":"BRTX","issuer_name_source":null,"issuer_url":"/issuer/0001505497","owner_cik":"0001527241","owner_name":"Silva Francisco","owner_display_name":"Silva Francisco","owner_url":"/insider/0001527241","role":"Director, Officer (VP of Research and Development)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Research and Development","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":725.0,"shares_display":"725","price_per_share":3.3884,"price_display":"3.39","price_state":"stated","total_value":2456.59,"total_display":"2,456.59","total_whole":"2,457","shares_owned_after":165103.0,"shares_owned_after_display":"165,103","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-12","filed_date":"2022-10-12","scope":"insider"},{"id":6434466,"accession":"0001567619-22-018424","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-22-018424","line_url":"/filing/0001567619-22-018424#line-1","is_derivative":false,"issuer_cik":"0001505497","issuer_name":"BioRestorative Therapies, Inc.","issuer_ticker":"BRTX","issuer_name_source":null,"issuer_url":"/issuer/0001505497","owner_cik":"0001527241","owner_name":"Silva Francisco","owner_display_name":"Silva Francisco","owner_url":"/insider/0001527241","role":"Director, Officer (VP of Research and Development)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Research and Development","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":806.0,"shares_display":"806","price_per_share":3.6886,"price_display":"3.69","price_state":"stated","total_value":2973.0116,"total_display":"2,973.01","total_whole":"2,973","shares_owned_after":164378.0,"shares_owned_after_display":"164,378","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-11","filed_date":"2022-10-12","scope":"insider"},{"id":6938686,"accession":"0001567619-22-017246","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001567619-22-017246","line_url":"/filing/0001567619-22-017246","is_derivative":false,"issuer_cik":"0001505497","issuer_name":"BioRestorative Therapies, Inc.","issuer_ticker":"BRTX","issuer_name_source":null,"issuer_url":"/issuer/0001505497","owner_cik":"0001527241","owner_name":"Silva Francisco","owner_display_name":"Silva Francisco","owner_url":"/insider/0001527241","role":"Director, Officer (VP of Research and Development)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Research and Development","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3123.0,"shares_display":"3,123","price_per_share":3.223420108869677,"price_display":"3.22","price_state":"stated","total_value":10066.741,"total_display":"10,066.74","total_whole":"10,067","shares_owned_after":163572.0,"shares_owned_after_display":"163,572","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-29","filed_date":"2022-09-09","scope":"insider","n_lines":2},{"id":6938680,"accession":"0001567619-22-017246","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-22-017246","line_url":"/filing/0001567619-22-017246#line-2","is_derivative":false,"issuer_cik":"0001505497","issuer_name":"BioRestorative Therapies, Inc.","issuer_ticker":"BRTX","issuer_name_source":null,"issuer_url":"/issuer/0001505497","owner_cik":"0001527241","owner_name":"Silva Francisco","owner_display_name":"Silva Francisco","owner_url":"/insider/0001527241","role":"Director, Officer (VP of Research and Development)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Research and Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3958.0,"shares_display":"3,958","price_per_share":3.388,"price_display":"3.39","price_state":"stated","total_value":13409.704,"total_display":"13,409.70","total_whole":"13,410","shares_owned_after":158156.0,"shares_owned_after_display":"158,156","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-26","filed_date":"2022-09-09","scope":"insider"},{"id":6938677,"accession":"0001567619-22-017246","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-22-017246","line_url":"/filing/0001567619-22-017246#line-1","is_derivative":false,"issuer_cik":"0001505497","issuer_name":"BioRestorative Therapies, Inc.","issuer_ticker":"BRTX","issuer_name_source":null,"issuer_url":"/issuer/0001505497","owner_cik":"0001527241","owner_name":"Silva Francisco","owner_display_name":"Silva Francisco","owner_url":"/insider/0001527241","role":"Director, Officer (VP of Research and Development)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Research and Development","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2600.0,"shares_display":"2,600","price_per_share":3.35,"price_display":"3.35","price_state":"stated","total_value":8710.0,"total_display":"8,710.00","total_whole":"8,710","shares_owned_after":160756.0,"shares_owned_after_display":"160,756","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-26","filed_date":"2022-09-09","scope":"insider"},{"id":4108829,"accession":"0001567619-21-020924","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-21-020924","line_url":"/filing/0001567619-21-020924#line-1","is_derivative":false,"issuer_cik":"0001505497","issuer_name":"BioRestorative Therapies, Inc.","issuer_ticker":"BRTX","issuer_name_source":null,"issuer_url":"/issuer/0001505497","owner_cik":"0001527241","owner_name":"Silva Francisco","owner_display_name":"Silva Francisco","owner_url":"/insider/0001527241","role":"Director, Officer (VP of Research and Development)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Research and Development","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":6.6565,"price_display":"6.66","price_state":"stated","total_value":26626.0,"total_display":"26,626.00","total_whole":"26,626","shares_owned_after":11829.0,"shares_owned_after_display":"11,829","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-19","filed_date":"2021-11-22","scope":"insider"},{"id":4108776,"accession":"0001567619-21-020585","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-21-020585","line_url":"/filing/0001567619-21-020585","is_derivative":false,"issuer_cik":"0001505497","issuer_name":"BioRestorative Therapies, Inc.","issuer_ticker":"BRTX","issuer_name_source":null,"issuer_url":"/issuer/0001505497","owner_cik":"0001527241","owner_name":"Silva Francisco","owner_display_name":"Silva Francisco","owner_url":"/insider/0001527241","role":"Director, Officer (VP of Research and Development)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Research and Development","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7826.0,"shares_display":"7,826","price_per_share":6.725221058011756,"price_display":"6.73","price_state":"stated","total_value":52631.58,"total_display":"52,631.58","total_whole":"52,632","shares_owned_after":7829.0,"shares_owned_after_display":"7,829","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-16","filed_date":"2021-11-16","scope":"insider","n_lines":2},{"id":8074493,"accession":"0001567619-19-018006","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-19-018006","line_url":"/filing/0001567619-19-018006","is_derivative":false,"issuer_cik":"0001505497","issuer_name":"BioRestorative Therapies, Inc.","issuer_ticker":"BRTX","issuer_name_source":null,"issuer_url":"/issuer/0001505497","owner_cik":"0001527241","owner_name":"Silva Francisco","owner_display_name":"Silva Francisco","owner_url":"/insider/0001527241","role":"Officer (VP of Research and Development)","role_mark":"O","role_mark_label":"Officer (VP of Research and Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Research and Development","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20955.0,"shares_display":"20,955","price_per_share":0.23946313528990695,"price_display":"0.24","price_state":"stated","total_value":5017.95,"total_display":"5,017.95","total_whole":"5,018","shares_owned_after":55958.0,"shares_owned_after_display":"55,958","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-04","filed_date":"2019-09-06","scope":"insider","n_lines":2},{"id":7791459,"accession":"0001567619-19-017786","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001567619-19-017786","line_url":"/filing/0001567619-19-017786","is_derivative":false,"issuer_cik":"0001505497","issuer_name":"BioRestorative Therapies, Inc.","issuer_ticker":"BRTX","issuer_name_source":null,"issuer_url":"/issuer/0001505497","owner_cik":"0001527241","owner_name":"Silva Francisco","owner_display_name":"Silva Francisco","owner_url":"/insider/0001527241","role":"Officer (VP of Research and Development)","role_mark":"O","role_mark_label":"Officer (VP of Research and Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Research and Development","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":18000.0,"shares_display":"18,000","price_per_share":0.27719444444444447,"price_display":"0.28","price_state":"stated","total_value":4989.5,"total_display":"4,989.50","total_whole":"4,990","shares_owned_after":35003.0,"shares_owned_after_display":"35,003","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-30","filed_date":"2019-09-03","scope":"insider","n_lines":3},{"id":8610577,"accession":"0001567619-19-017635","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-19-017635","line_url":"/filing/0001567619-19-017635","is_derivative":false,"issuer_cik":"0001505497","issuer_name":"BioRestorative Therapies, Inc.","issuer_ticker":"BRTX","issuer_name_source":null,"issuer_url":"/issuer/0001505497","owner_cik":"0001527241","owner_name":"Silva Francisco","owner_display_name":"Silva Francisco","owner_url":"/insider/0001527241","role":"Officer (VP of Research and Development)","role_mark":"O","role_mark_label":"Officer (VP of Research and Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Research and Development","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7500.0,"shares_display":"7,500","price_per_share":0.26866666666666666,"price_display":"0.27","price_state":"stated","total_value":2015.0,"total_display":"2,015.00","total_whole":"2,015","shares_owned_after":17003.0,"shares_owned_after_display":"17,003","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-26","filed_date":"2019-08-28","scope":"insider","n_lines":2},{"id":8329483,"accession":"0001567619-19-017530","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-19-017530","line_url":"/filing/0001567619-19-017530","is_derivative":false,"issuer_cik":"0001505497","issuer_name":"BioRestorative Therapies, Inc.","issuer_ticker":"BRTX","issuer_name_source":null,"issuer_url":"/issuer/0001505497","owner_cik":"0001527241","owner_name":"Silva Francisco","owner_display_name":"Silva Francisco","owner_url":"/insider/0001527241","role":"Officer (VP of Research and Development)","role_mark":"O","role_mark_label":"Officer (VP of Research and Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Research and Development","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":17374.0,"shares_display":"17,374","price_per_share":0.2558880165764936,"price_display":"0.26","price_state":"stated","total_value":4445.7984,"total_display":"4,445.80","total_whole":"4,446","shares_owned_after":13003.0,"shares_owned_after_display":"13,003","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-22","filed_date":"2019-08-23","scope":"insider","n_lines":2},{"id":5020488,"accession":"0001140361-17-009952","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001140361-17-009952","line_url":"/filing/0001140361-17-009952#line-6","is_derivative":false,"issuer_cik":"0001505497","issuer_name":"BioRestorative Therapies, Inc.","issuer_ticker":"BRTX","issuer_name_source":null,"issuer_url":"/issuer/0001505497","owner_cik":"0001527241","owner_name":"Silva Francisco","owner_display_name":"Silva Francisco","owner_url":"/insider/0001527241","role":"Officer (VP of Research and Development)","role_mark":"O","role_mark_label":"Officer (VP of Research and Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Research and Development","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1800.0,"shares_display":"1,800","price_per_share":4.38,"price_display":"4.38","price_state":"stated","total_value":7884.0,"total_display":"7,884.00","total_whole":"7,884","shares_owned_after":4075.0,"shares_owned_after_display":"4,075","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-09","filed_date":"2017-03-01","scope":"insider"},{"id":5020483,"accession":"0001140361-17-009952","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001140361-17-009952","line_url":"/filing/0001140361-17-009952#line-5","is_derivative":false,"issuer_cik":"0001505497","issuer_name":"BioRestorative Therapies, Inc.","issuer_ticker":"BRTX","issuer_name_source":null,"issuer_url":"/issuer/0001505497","owner_cik":"0001527241","owner_name":"Silva Francisco","owner_display_name":"Silva Francisco","owner_url":"/insider/0001527241","role":"Officer (VP of Research and Development)","role_mark":"O","role_mark_label":"Officer (VP of Research and Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Research and Development","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2250.0,"shares_display":"2,250","price_per_share":4.25,"price_display":"4.25","price_state":"stated","total_value":9562.5,"total_display":"9,562.50","total_whole":"9,563","shares_owned_after":2275.0,"shares_owned_after_display":"2,275","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-02","filed_date":"2017-03-01","scope":"insider"},{"id":5020479,"accession":"0001140361-17-009952","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-17-009952","line_url":"/filing/0001140361-17-009952#line-4","is_derivative":false,"issuer_cik":"0001505497","issuer_name":"BioRestorative Therapies, Inc.","issuer_ticker":"BRTX","issuer_name_source":null,"issuer_url":"/issuer/0001505497","owner_cik":"0001527241","owner_name":"Silva Francisco","owner_display_name":"Silva Francisco","owner_url":"/insider/0001527241","role":"Officer (VP of Research and Development)","role_mark":"O","role_mark_label":"Officer (VP of Research and Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Research and Development","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20.0,"shares_display":"20","price_per_share":7.6,"price_display":"7.60","price_state":"stated","total_value":152.0,"total_display":"152.00","total_whole":"152","shares_owned_after":170.0,"shares_owned_after_display":"170","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-06-11","filed_date":"2017-03-01","scope":"insider"},{"id":5020475,"accession":"0001140361-17-009952","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-17-009952","line_url":"/filing/0001140361-17-009952#line-3","is_derivative":false,"issuer_cik":"0001505497","issuer_name":"BioRestorative Therapies, Inc.","issuer_ticker":"BRTX","issuer_name_source":null,"issuer_url":"/issuer/0001505497","owner_cik":"0001527241","owner_name":"Silva Francisco","owner_display_name":"Silva Francisco","owner_url":"/insider/0001527241","role":"Officer (VP of Research and Development)","role_mark":"O","role_mark_label":"Officer (VP of Research and Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Research and Development","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25.0,"shares_display":"25","price_per_share":7.6,"price_display":"7.60","price_state":"stated","total_value":190.0,"total_display":"190.00","total_whole":"190","shares_owned_after":25.0,"shares_owned_after_display":"25","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-06-10","filed_date":"2017-03-01","scope":"insider"},{"id":5020468,"accession":"0001140361-17-009952","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-17-009952","line_url":"/filing/0001140361-17-009952#line-2","is_derivative":false,"issuer_cik":"0001505497","issuer_name":"BioRestorative Therapies, Inc.","issuer_ticker":"BRTX","issuer_name_source":null,"issuer_url":"/issuer/0001505497","owner_cik":"0001527241","owner_name":"Silva Francisco","owner_display_name":"Silva Francisco","owner_url":"/insider/0001527241","role":"Officer (VP of Research and Development)","role_mark":"O","role_mark_label":"Officer (VP of Research and Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Research and Development","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100.0,"shares_display":"100","price_per_share":10.4,"price_display":"10.40","price_state":"stated","total_value":1040.0,"total_display":"1,040.00","total_whole":"1,040","shares_owned_after":150.0,"shares_owned_after_display":"150","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-12-26","filed_date":"2017-03-01","scope":"insider"},{"id":5020462,"accession":"0001140361-17-009952","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-17-009952","line_url":"/filing/0001140361-17-009952#line-1","is_derivative":false,"issuer_cik":"0001505497","issuer_name":"BioRestorative Therapies, Inc.","issuer_ticker":"BRTX","issuer_name_source":null,"issuer_url":"/issuer/0001505497","owner_cik":"0001527241","owner_name":"Silva Francisco","owner_display_name":"Silva Francisco","owner_url":"/insider/0001527241","role":"Officer (VP of Research and Development)","role_mark":"O","role_mark_label":"Officer (VP of Research and Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Research and Development","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50.0,"shares_display":"50","price_per_share":10.4,"price_display":"10.40","price_state":"stated","total_value":520.0,"total_display":"520.00","total_whole":"520","shares_owned_after":50.0,"shares_owned_after_display":"50","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-07-17","filed_date":"2017-03-01","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":30,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":29,"open_market":true},{"code":"S","label":"Open-market sale","n":1,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":30},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001505497","name":"BioRestorative Therapies, Inc.","url":"/issuer/0001505497","role":"Director, Officer (VP of Research and Development), Ten percent owner","n_filings":14,"first_seen":"2017-03-01","last_seen":"2024-04-10"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001527241","retrieved_at":"2026-08-25T06:05:01+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}